Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data

Overview of attention for article published in OncoTargets and therapy, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 1 news story.

The emergence of novel agents, including CAR T-cell therapies and antibody-drug conjugates, plus existing options such as…